Literature DB >> 7129819

Brominated radiopaque liposomes: contrast agent for computed tomography of liver and spleen: a preliminary report.

V J Caride, H D Sostman, J Twickler, H Zacharis, S C Orphanoudakis, C C Jaffe.   

Abstract

Contrast enhancement of liver and spleen in the dog was obtained after intravenous administration of brominated radioopaque liposomes (ROL) (1-5 micron in diameter. Computed tomographic (CT) numbers generated before and after 3 hours of ROL administration demonstrated an increase in hepatic attenuation. ROL are biodegradable lipid vesicles that can be subjected to further physicochemical modifications (size, charge composition) that alter their biodistribution and pharmacokinetics. These changes can result in improved hepatosplenic contrast enhancement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129819

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  Intraneoplastic application of metrizamide-containing liposomes: kinetic studies with computed tomography.

Authors:  B Wowra; K Cremer; H Stricker; W J Zeller
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

Review 2.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Authors:  G Gregoriadis; A T Florence
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 3.  Nanoparticle contrast agents for computed tomography: a focus on micelles.

Authors:  David P Cormode; Pratap C Naha; Zahi A Fayad
Journal:  Contrast Media Mol Imaging       Date:  2014 Jan-Feb       Impact factor: 3.161

4.  Gold-coated plant virus as computed tomography imaging contrast agent.

Authors:  Alaa A A Aljabali; Mazhar S Al Zoubi; Khalid M Al-Batanyeh; Ali Al-Radaideh; Mohammad A Obeid; Abeer Al Sharabi; Walhan Alshaer; Bayan AbuFares; Tasnim Al-Zanati; Murtaza M Tambuwala; Naveed Akbar; David J Evans
Journal:  Beilstein J Nanotechnol       Date:  2019-10-07       Impact factor: 3.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.